VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 146 filers reported holding VIKING THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $24,214,851 | -18.2% | 456,799 | +26.6% | 0.01% | -17.6% |
Q1 2024 | $29,588,798 | +14205.7% | 360,839 | +3146.7% | 0.02% | – |
Q4 2023 | $206,832 | +84.2% | 11,114 | +9.6% | 0.00% | – |
Q3 2023 | $112,283 | -39.0% | 10,143 | -10.6% | 0.00% | – |
Q2 2023 | $184,000 | +100.0% | 11,351 | -22.9% | 0.00% | – |
Q3 2021 | $92,000 | -10.7% | 14,727 | -13.9% | 0.00% | – |
Q2 2021 | $103,000 | +1.0% | 17,114 | +5.9% | 0.00% | – |
Q1 2021 | $102,000 | +20.0% | 16,168 | +7.6% | 0.00% | – |
Q4 2020 | $85,000 | -1.2% | 15,031 | +2.2% | 0.00% | – |
Q3 2020 | $86,000 | -22.5% | 14,702 | -4.7% | 0.00% | – |
Q2 2020 | $111,000 | +126.5% | 15,430 | +46.4% | 0.00% | – |
Q1 2020 | $49,000 | -42.4% | 10,541 | 0.0% | 0.00% | – |
Q4 2019 | $85,000 | – | 10,541 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |